共 50 条
- [31] 5-aminosalicylates are not associated with adverse outcomes in Inflammatory Bowel Disease patients with COVID-19: Analysis from an international registry JOURNAL OF CROHNS & COLITIS, 2021, 15 : S006 - S007
- [32] 5-ASAs in Crohn’s Disease: Time to Stop the Salicylate? Digestive Diseases and Sciences, 2022, 67 : 2699 - 2700
- [33] Efficacy of 5-Aminosalicylates for the Maintenance of Remission in Crohn's Disease AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (10): : 1857 - 1857
- [37] 5-Aminosalicylates to Prevent Relapse of Crohn's Disease After Surgery AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (03): : 487 - 487
- [38] Systematic Review of the use of metabonomics in inflammatory bowel disease (IBD) JOURNAL OF CROHNS & COLITIS, 2015, 9 : S99 - S100
- [40] 5-Aminosalicylates Prevent Relapse of Crohn's Disease After Surgically Induced Remission: Systematic Review and Meta-Analysis AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (03): : 413 - 420